Home › Funds › Geode Capital Management › BBIO
Geode Capital Management position in BBIO
BRIDGEBIO PHARMA INC · Health Care
Latest position (Q2 2026)3.42M sh
Reported value held$254.67M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.95M | $91.26M | New |
| Q4 2021 | 1.93M | $32.15M | Reduce |
| Q1 2022 | 1.78M | $18.11M | Reduce |
| Q2 2022 | 1.97M | $17.89M | Add |
| Q3 2022 | 1.96M | $19.52M | Hold |
| Q4 2022 | 2.07M | $15.74K | Add |
| Q1 2023 | 2.25M | $37.36M | Add |
| Q2 2023 | 2.42M | $41.61M | Add |
| Q3 2023 | 2.51M | $66.23M | Add |
| Q4 2023 | 2.71M | $109.58M | Add |
| Q1 2024 | 2.86M | $88.53M | Add |
| Q2 2024 | 3.29M | $83.36M | Add |
| Q3 2024 | 3.41M | $86.94M | Add |
| Q4 2024 | 3.42M | $93.80M | Hold |
| Q1 2025 | 3.50M | $121.12M | Add |
| Q2 2025 | 3.68M | $158.99M | Add |
| Q3 2025 | 3.91M | $203.11M | Add |
| Q4 2025 | 4.41M | $344.69M | Add |
| Q1 2026 | 4.92M | $371.93M | Add |
| Q2 2026 | 3.42M | $254.67M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBIO
- Vanguard Group 16.86M sh · $1.29B · Q4 2025
- Janus Henderson Group 13.18M sh · $978.61M · Q1 2026
- Farallon Capital Management 10.74M sh · $800.14M · Q2 2026
- Viking Global Investors 9.95M sh · $741.02M · Q2 2026
- Two Sigma Investments 4.75M sh · $353.43M · Q2 2026
- D. E. Shaw & Co 3.66M sh · $272.89M · Q2 2026
- Manulife Financial 1.96M sh · $145.66M · Q2 2026
- Charles Schwab Investment Management 1.71M sh · $127.32M · Q2 2026
- Norges Bank Investment Management 1.69M sh · $126.15M · Q2 2026
- Morgan Stanley 1.69M sh · $126.14M · Q2 2026
- Point72 Asset Management 1.53M sh · $114.16M · Q2 2026